A Phase 1 study of RAD1901, an oral selective estrogen receptor degrader, in ER positive, HER2 negative, advanced breast cancer patients.

Elisabeth De Vries; Clasina Marieke Venema; Andor W. J. M. Glaudemans; Lorraine Fitzpatrick; Dinesh Purandare; Gary Hattersley; Fiona Garner

doi:10.1200/jco.2016.34.15_suppl.tps627

A Phase 1 study of RAD1901, an oral selective estrogen receptor degrader, in ER positive, HER2 negative, advanced breast cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.tps627 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. TPS627-TPS627 ◽

Cited By ~ 2

Author(s):

Elisabeth De Vries ◽

Clasina Marieke Venema ◽

Andor W. J. M. Glaudemans ◽

Lorraine Fitzpatrick ◽

Dinesh Purandare ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Phase 1 ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Phase 1 Study ◽

Er Positive

Download Full-text

Abstract P2-08-08: A phase 1 study of RAD1901, an oral selective estrogen receptor degrader, to determine changes in the18F-FES uptake and tumor responses in ER-positive, HER2-negative, advanced breast cancer patients

10.1158/1538-7445.sabcs16-p2-08-08 ◽

2017 ◽

Author(s):

EGE de Vries ◽

CM Venema ◽

AWJM Glaudemans ◽

A Jager ◽

F Garner ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Phase 1 ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Phase 1 Study ◽

Er Positive

Download Full-text

Abstract P1-10-04: Elacestrant, a novel oral selective estrogen receptor degrader (SERD), decreases tumoral 18F-FES uptake in a phase 1 study of ER+, HER2 -, advanced breast cancer patients

10.1158/1538-7445.sabcs17-p1-10-04 ◽

2018 ◽

Author(s):

EGE de Vries ◽

CM Venema ◽

AWJM Glaudemans ◽

A Jager ◽

CW Menke-van der Houven van Oordt ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Phase 1 ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Phase 1 Study

Download Full-text

Abstract P2-08-06: A phase 1 study of RAD1901, a novel, oral selective estrogen receptor degrader, for the treatment of ER-positive advanced breast cancer

10.1158/1538-7445.sabcs16-p2-08-06 ◽

2017 ◽

Author(s):

VG Kaklamani ◽

P Kabos ◽

R Elledge ◽

W Harb ◽

D Purandare ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Phase 1 ◽

Advanced Breast ◽

Phase 1 Study ◽

Er Positive

Download Full-text

Abstract OT2-01-10: A phase 1 study of RAD1901, a novel, orally available, selective estrogen receptor degrader, for the treatment of ER positive advanced breast cancer

10.1158/1538-7445.sabcs15-ot2-01-10 ◽

2016 ◽

Cited By ~ 1

Author(s):

W Harb ◽

F Garner ◽

J McDermott ◽

T Zimmerman ◽

G Williams ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Phase 1 ◽

Advanced Breast ◽

Phase 1 Study ◽

Er Positive

Download Full-text

Abstract PD4-05: Patterns of genomic alterations in ER-positive advanced breast cancer patients treated with CDK4/6 inhibitors

10.1158/1538-7445.sabcs17-pd4-05 ◽

2018 ◽

Cited By ~ 1

Author(s):

MR Cruz ◽

K Limentani ◽

T Taxter ◽

CA Santa-Maria ◽

A Behdad ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Genomic Alterations ◽

Er Positive

Download Full-text

Palbociclib plus letrozole as first-line treatment for ER-positive and HER2-negative advanced breast cancer in Chinese women: a phase 1 study

The Lancet Oncology ◽

10.1016/s1470-2045(17)30763-5 ◽

2017 ◽

Vol 18 ◽

pp. S7 ◽

Cited By ~ 1

Author(s):

Huiping Li ◽

Qingyuan Zhang ◽

Wei Li ◽

Shusen Wang ◽

Ning Liao ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Chinese Women ◽

Phase 1 ◽

Advanced Breast ◽

Line Treatment ◽

First Line ◽

Phase 1 Study ◽

Er Positive ◽

First Line Treatment

Download Full-text

Erratum to: Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

Breast Cancer Research ◽

10.1186/bcr1606 ◽

2006 ◽

Vol 8 (5) ◽

Cited By ~ 6

Author(s):

Elisabetta Munzone ◽

Giuseppe Curigliano ◽

Andrea Rocca ◽

Giuseppina Bonizzi ◽

Giuseppe Renne ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Her 2 ◽

Estrogen Receptor Negative ◽

Negative Phenotype

Download Full-text

Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

Breast Cancer Research ◽

10.1186/bcr1366 ◽

2005 ◽

Vol 8 (1) ◽

Cited By ~ 40

Author(s):

Elisabetta Munzone ◽

Giuseppe Curigliano ◽

Andrea Rocca ◽

Giuseppina Bonizzi ◽

Giuseppe Renne ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Her 2 ◽

Estrogen Receptor Negative ◽

Negative Phenotype

Download Full-text

Clinical and genetic risk factors for Fulvestrant treatment in post-menopause ER-positive advanced breast cancer patients

Journal of Translational Medicine ◽

10.1186/s12967-018-1734-x ◽

2019 ◽

Vol 17 (1) ◽

Cited By ~ 9

Author(s):

Jingyu Liu ◽

Jing Li ◽

Hui Wang ◽

Yikai Wang ◽

Qiongzhi He ◽

...

Keyword(s):

Breast Cancer ◽

Risk Factors ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Genetic Risk ◽

Genetic Risk Factors ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Er Positive ◽

Post Menopause

Download Full-text

Poor Marital Quality Affects Psychological Distress and Immunity in Advanced Breast Cancer Patients

PsycEXTRA Dataset ◽

10.1037/e582332013-001 ◽

2013 ◽

Author(s):

Tammy A. Schuler ◽

Barbara L. Andersen

Keyword(s):

Breast Cancer ◽

Psychological Distress ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Marital Quality ◽

Advanced Breast ◽

Breast Cancer Patients

Download Full-text